GLIS1 and posterior cortical atrophy: In vitro and in vivo experiments will help us detect the efficacy of GLIS1 in enhancing PCa immunotherapy, such as the potential synergistic effect in combination with immune checkpoint inhibitors in PCa immunotherapy.